Amylin Pharma (AMLN) Posts Wider than Expected Q2 Loss; Revs Beat
Tweet Send to a FriendGet Alerts AMLN Hot Sheet
Price: $30.98 --0%
EPS Growth %: +4.2%
Financial Fact:
Net loss: -99.04M
Today's EPS Names:
MPAA, LTON, KFY, More
EPS Growth %: +4.2%
Financial Fact:
Net loss: -99.04M
Today's EPS Names:
MPAA, LTON, KFY, More
Trade AMLN Now!
Amylin Pharma (NASDAQ: AMLN) reported Q2 loss of ($0.21), $0.03 worse than the analyst estimate of ($0.18). Revenue for the quarter came in at $158.07 million versus the consensus estimate of $157.72 million.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Five Below (FIVE) Tops Q1 EPS by 1c, Boosts FY13 Outlook
- American Superconductor (AMSC) Reports In-Line Q4 EPS; Guides Q1
- Restoration Hardware Holdings (RH) Tops Q1 EPS by 2c, Guidance Beat
Create E-mail Alert Related Categories
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
